View online | Unsubscribe (one-click).
For inquiries/unsubscribe issues, Contact Us


?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng
?
?
Learn more about Jeeng













You Might Like
? ?
?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...


?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...













Want to accelerate software development at your company? See how we can help.
Want to accelerate software development at your company? See how we can help.




Want to accelerate software development at your company? See how we can help.
Want to accelerate software development at your company? See how we can help.




Want to accelerate software development at your company? See how we can help.


The Second Person to Get a Pig Heart Transplant Just Died - WIRED   

Lawrence Faucette, the 58-year-old patient with terminal heart disease who was the second person to receive a genetically engineered pig heart, died on October 30, according to a statement from the University of Maryland Medical Center in Baltimore, where the transplant was performed.

Faucette received the transplant on September 20 and lived for six weeks—less time than the first recipient, despite extra precautions by the Maryland team. Initially, Faucette made progress following his surgery. He was doing physical therapy, spending time with family members, and playing cards with his wife, according to the university. But in the days leading up to his death, his heart began to show signs of organ rejection; in other words, his immune system recognized the pig heart as foreign and attacked it. Rejection is also the biggest challenge with traditional transplants involving human organs.

At the University of Maryland Medical Center and elsewhere, researchers have been studying the possibility of transplanting animal organs into people—known as xenotransplantation—as a way to ease the human organ shortage. In the United States, more than 103,000 people are on the national transplant waiting list, and 17 people die each day waiting for an organ. Because donor organs are a scarce resource, doctors want to select patients for transplants who are likely to survive the transplant and go on to do well after surgery.

Continued here








You are receiving this mailer as a TradeBriefs subscriber.
We fight fake/biased news through human curation & independent editorials.
Your support of ads like these makes it possible. Alternatively, get TradeBriefs Premium (ad-free) for only $2/month
If you still wish to unsubscribe, you can unsubscribe from all our emails here
Our address is 309 Town Center 1, Andheri Kurla Road, Andheri East, Mumbai 400059 - 93544947